Biotechnology

Passive equity products have become popular over the past decade as it has become easier and cheaper to track the performance of an index.

Ceremony takes place on Wednesday 20 November

Average rate hit nearly 1.5% in May

The themes to look out for

When it comes to finding growth in the UK, we are positive on the pharmaceuticals sector.

What should investors look out for?

Biotech and healthcare is leading sector

'Diminishing regulatory barriers'

INDUSTRY VOICE: Major headwinds caused by various factors weighed on investor sentiment in the healthcare sector during the second quarter. BB Biotech was not completely immune to these developments and delivered a return of 1.2% in EUR.

INDUSTRY VOICE: Big players in the healthcare sector are desperate to differentiate their approved 'checkpoint inhibitors' (a drug that unleashes an immune system attack on cancer cells) by combining their use with conventional chemotherapy or other new...